Sorry, you need to enable JavaScript to visit this website.

Disease management

Subject Hierarchy
Broader terms
Illness
Current term
Disease management
Permalinks
APO URI

ADVERTISEMENT

Report

Managing the next crisis: twelve principles for dealing with viral uncertainty


Governments and societies continue to face the unforeseen and unprecedented challenges of responding to and recovering from the COVID-19 pandemic. In this report, the authors—renowned experts on governance at all levels—step back to understand how governments have operated in developing strategies and programs to address these global and societal challenges.
Report

COVID income support: analysis of income support in the COVID lockdowns in 2020 and 2021


This report analyses a range of interactive maps, prepared to provide the first geographic snapshot of people on income support payments who also received COVID-specific income support payments across the country in the first wave of the pandemic in 2020, the 'Alpha' wave.
Draft report

Report on public hearing 12: The experiences of people with disability, in the context of the Australian government’s approach to the COVID-19 vaccine rollout


In May 2021, the Royal Commission conducted a public hearing in Sydney considering the experiences of people with disability, in the context of the Australian government’s approach to the COVID-19 vaccine rollout. This is the report of the three Commissioners who participated in the hearing.
Conference proceedings

Youth mental health and COVID-19: 2021 Policy Lab briefing note


This paper summaries the discussions that emerged from a conference exploring the impacts of COVID-19 and related responses on the mental health of young people in disadvantaged, marginalised and vulnerable groups in the United Kingdom.
Report

A double dose of inequality: pharma companies and the COVID-19 vaccines crisis


This report focuses on six leading vaccine developers, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.